🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will be a randomised, open-label, 3-period, 3-treatment, single-...
Status
Completed
Location
Research Site
Start Date
2021-02-01
Trial ID
NCT04734275
Treatments Being Tested
This will be a randomized, single dose, open-label, three-treatment period ...
Status
Completed
Location
Multiple Locations
Start Date
2013-07
Trial ID
NCT02723630
Treatments Being Tested
The main objective of this trial is to compare the pharmacokinetics (PK) of...
Status
Completed
Location
Miami Research Associates, Inc
Start Date
2022-02-18
Trial ID
NCT05203289
Treatments Being Tested
The purpose of this study is to assess, after single oral administration un...
Status
Withdrawn
Location
Arab Pharmaceutical industry Consulting/ Pharmaceutical Research Unit
Start Date
2015-05
Trial ID
NCT02395237
Treatments Being Tested
Part 1 of the study will be conducted to provide additional information on ...
Status
Completed
Location
Quotient Sciences
Start Date
2018-03-21
Trial ID
NCT03464058
This is an open-label, randomized, two treatment, two sequences, two period...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-02-25
Trial ID
NCT01711749
Treatments Being Tested
The study will be conducted in participants with type1 diabetes on insulin ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2018-01
Trial ID
NCT02623452
Treatments Being Tested
This is a single-center, single-dose, randomized, open-label, parallel sstu...
Status
Unknown
Location
The Second Affiliated Hospital of Guangzhou Medical University
Start Date
2021-01-06
Trial ID
NCT04903158
Treatments Being Tested
Objective: to compare the single dose bioavailability of Torrent's Losarta...
Status
Completed
Location
Torrent BE Centre
Start Date
TBD
Trial ID
NCT01218724
Treatments Being Tested
The purpose of the study is to evaluate the local tolerability and the syst...
Status
Completed
Location
CROSS Research S.A., Phase I Unit, Via F.A. Giorgioli 14 Phone: Fax: +41.91.63.00.511 Email:
Start Date
2017-11-14
Trial ID
NCT03706781